Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Case Studies in Rare Disease Commercialization: Lessons Learned What Matters to Payers: Conversations You Should Start During Phase 2 Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Case Studies in Rare Disease Commercialization: Lessons Learned What Matters to Payers: Conversations You Should Start During Phase 2 Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
